Elixirgen Scientific Japan

Elixirgen Scientific Japan is a biotechnology company specializing in the rapid differentiation of human induced pluripotent stem cells (iPSCs) into various functional cell types. Utilizing its proprietary Quick-Tissue technology, which employs synthetic mRNA to drive cellular transformation, the company provides high-quality human cells and kits for drug discovery, toxicology, and basic research. The company's platform significantly reduces differentiation timelines from months to approximately one week, enabling faster and more scalable disease modeling. As a subsidiary of Elixirgen Scientific (now part of Axol Bioscience), the Japan-based entity serves the Asian market with specialized cell-based assays and custom differentiation services. Their products include iPSC-derived neurons, muscle cells, and hepatocytes, which are used by pharmaceutical companies to improve the predictive accuracy of preclinical studies.